Alaunos Therapeutics
(NASDAQ) TCRT
Alaunos Therapeutics Financials at a Glance
Market Cap
$6.65M
Revenue (TTM)
$6.00K
Net Income (TTM)
$4.03M
EPS (TTM)
$-2.31
P/E Ratio
-1.29
Dividend
$0.00
Beta (Volatility)
1.44 (Average)
Dividend
$0.00
Beta (Volatility)
1.44 (Average)
Price
$2.97
Volume
150
Open
$2.97
Price
$2.97
Volume
150
Open
$2.97
Previous Close
$2.97
Daily Range
$2.97 - $2.97
52-Week Range
$1.31 - $6.20
Dividend
$0.00
Beta (Volatility)
1.44 (Average)
Price
$2.97
Volume
150
Open
$2.97
Previous Close
$2.97
Daily Range
$2.97 - $2.97
52-Week Range
$1.31 - $6.20
TCRT News
TCRT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Alaunos Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
1
CEO
Holger Weis, CPA
Website
www.alaunos.comHeadquarters
Houston, TX 77054, US
TCRT Financials
Key Financial Metrics (TTM)
Gross Margin
-30%
Operating Margin
-679%
Net Income Margin
-671%
Return on Equity
-146%
Return on Capital
-1%
Return on Assets
-1%
Earnings Yield
-77.52%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.65M
Shares Outstanding
2.23M
Volume
150
Short Interest
0.00%
Avg. Volume
20.19K
Financials (TTM)
Gross Profit
$10.00K
Operating Income
$4.81M
EBITDA
$4.68M
Operating Cash Flow
$4.97M
Capital Expenditure
$0.00
Free Cash Flow
$4.97M
Cash & ST Invst.
$1.09M
Total Debt
$0.00
Alaunos Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$6.65M
N/A
Market Cap/Employee
$6.65M
N/A
Employees
1
N/A
Net Income
$1.16M
-2.8%
EBITDA
$1.16M
-2.8%
Quarterly Fundamentals
Net Cash
$1.94M
+15.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-1.08%
N/A
Return on Invested Capital
-1.45%
N/A
Free Cash Flow
$941.00K
-20.5%
Operating Cash Flow
$844.00K
-8.1%